RU2017139241A - Способ получения клона стволовых клеток, пригодного для индуцирования дифференцировки в соматические клетки. - Google Patents
Способ получения клона стволовых клеток, пригодного для индуцирования дифференцировки в соматические клетки. Download PDFInfo
- Publication number
- RU2017139241A RU2017139241A RU2017139241A RU2017139241A RU2017139241A RU 2017139241 A RU2017139241 A RU 2017139241A RU 2017139241 A RU2017139241 A RU 2017139241A RU 2017139241 A RU2017139241 A RU 2017139241A RU 2017139241 A RU2017139241 A RU 2017139241A
- Authority
- RU
- Russia
- Prior art keywords
- cells
- differentiation
- induction
- stem cells
- somatic cells
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title claims 11
- 230000004069 differentiation Effects 0.000 title claims 10
- 210000001082 somatic cell Anatomy 0.000 title claims 9
- 230000001939 inductive effect Effects 0.000 title claims 3
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 238000000034 method Methods 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 10
- 230000006698 induction Effects 0.000 claims 6
- 210000002361 Megakaryocyte Progenitor Cell Anatomy 0.000 claims 3
- 230000032459 dedifferentiation Effects 0.000 claims 2
- 210000003593 megakaryocyte Anatomy 0.000 claims 2
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 claims 1
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 claims 1
- 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 claims 1
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims 1
- 102100020677 Krueppel-like factor 4 Human genes 0.000 claims 1
- 101100058550 Mus musculus Bmi1 gene Proteins 0.000 claims 1
- 108091057508 Myc family Proteins 0.000 claims 1
- 108700020796 Oncogene Proteins 0.000 claims 1
- 102000043276 Oncogene Human genes 0.000 claims 1
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 claims 1
- 102100023075 Protein Niban 2 Human genes 0.000 claims 1
- 108700025695 Suppressor Genes Proteins 0.000 claims 1
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims 1
- 101100022813 Zea mays MEG3 gene Proteins 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000001612 chondrocyte Anatomy 0.000 claims 1
- 210000000349 chromosome Anatomy 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 210000003494 hepatocyte Anatomy 0.000 claims 1
- 230000035800 maturation Effects 0.000 claims 1
- 210000002752 melanocyte Anatomy 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- 210000001982 neural crest cell Anatomy 0.000 claims 1
- 210000001178 neural stem cell Anatomy 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 210000003924 normoblast Anatomy 0.000 claims 1
- 108700042657 p16 Genes Proteins 0.000 claims 1
- 230000008672 reprogramming Effects 0.000 claims 1
- 210000002363 skeletal muscle cell Anatomy 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/603—Oct-3/4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/604—Klf-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/606—Transcription factors c-Myc
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (17)
1. Способ получения клона стволовых клеток, который содержит этапы:
(i) введения в стволовые клетки экзогенного гена, связанного с индукцией дифференцировки в соматические клетки;
(ii) индукции дифференцировки стволовых клеток, в которые введен экзогенный ген, в соматические клетки;
(iii) дедифференцировки индуцированных к дифференцировке соматических клеток; и
(iv) выделения стволовых клеток, несущих экзогенный ген, встроенный в их хромосому, из колонии стволовых клеток, образованных на этапе (iii).
2. Способ по п. 1, где эффективность индуцирования дифференцировки изолированных клонов стволовых клеток в соматические клетки выше по сравнению с эффективностью индуцирования дифференцировки стволовых клеток перед клонированием.
3. Способ по п. 1, где соматическими клетками являются гемопоэтические клетки-предшественники, клетки-предшественники мегакариоцитов, эритробласты, нервные клетки, нейральные стволовые клетки, клетки нервного гребня, миокардиальные клетки, клетки скелетных мышц, хондроциты, гепатоциты или меланоциты.
4. Способ по п. 3, где соматическими клетками являются клетки-предшественники мегакариоцитов, и экзогенный ген, связанный с индукцией дифференцировки является, по меньшей мере, одним экзогенным геном, выбранным из группы, состоящей из онкогенов, включая гены семейства MYC, гены (гены поликомб), ингибирующие экспрессию гена p16 или гена p19, включая Bmi1, и гены, подавляющие апоптоз, включая ген BCL-XL.
5. Способ в соответствии с п.1, где изолируют стволовые клетки, экспрессирующие MEG3.
6. Способ в соответствии с п.1, где экзогенный ген, связанный с индукцией дифференцировки, функционально связан с отвечающим на препарат промотором.
7. Способ в соответствии с п.1, где дедифференцировку на этапе (iii) проводят посредством введения репрограммирующего фактора, выбранного из группы, состоящей из OCT3/4, SOX2 и KLF4.
8. Способ получения соматических клеток, который содержит этап:
индукции дифференцировки клонов стволовых клеток, полученных в соответствии со способом в соответствии с п.1, в соматические клетки.
9. Способ получения тромбоцитов, который содержит этапы:
индукции дифференцировки клонов стволовых клеток, полученных в соответствии со способом в соответствии п.1 в клетки-предшественники мегакариоцитов; и
обеспечение созревания индуцированных к дифференцировке клеток-предшественников мегакариоцитов в мегакариоциты и высвобождения тромбоцитов.
10. Способ по п. 9, где полученные тромбоциты являются дефицитными по HLA.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015-082768 | 2015-04-14 | ||
| JP2015082768 | 2015-04-14 | ||
| PCT/JP2016/062040 WO2016167329A1 (ja) | 2015-04-14 | 2016-04-14 | 体細胞への分化誘導に適した幹細胞クローンを製造する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017139241A true RU2017139241A (ru) | 2019-05-14 |
| RU2017139241A3 RU2017139241A3 (ru) | 2019-09-16 |
| RU2730034C2 RU2730034C2 (ru) | 2020-08-14 |
Family
ID=57126279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017139241A RU2730034C2 (ru) | 2015-04-14 | 2016-04-14 | Способ получения клона стволовых клеток, пригодного для индуцирования дифференцировки в соматические клетки |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20180051260A1 (ru) |
| EP (1) | EP3296390B1 (ru) |
| JP (1) | JP6873898B2 (ru) |
| KR (1) | KR102563564B1 (ru) |
| CN (1) | CN107709543B (ru) |
| AU (1) | AU2016248858A1 (ru) |
| BR (1) | BR112017022219A2 (ru) |
| CA (1) | CA2982568A1 (ru) |
| IL (1) | IL255031B (ru) |
| RU (1) | RU2730034C2 (ru) |
| SG (1) | SG11201708395VA (ru) |
| WO (1) | WO2016167329A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108866005A (zh) * | 2018-07-20 | 2018-11-23 | 东南大学 | 一种永生化人源神经干细胞系及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1970446E (pt) * | 2005-12-13 | 2011-09-01 | Univ Kyoto | Factor de reprogramação nuclear |
| US20120034192A1 (en) * | 2008-09-19 | 2012-02-09 | Young Richard A | Compositions and methods for enhancing cell reprogramming |
| DK2356221T3 (en) * | 2008-10-24 | 2019-02-18 | Wisconsin Alumni Res Found | Pluripotent stem cells obtained by non-viral reprogramming |
| BR112012005710B1 (pt) * | 2009-09-15 | 2020-06-09 | Univ Tokyo | método para produzir células megacariotícas maduras, método para produzir um produto de plaqueta, método para produzir um produto sanguíneo, população celular, composição celular congelada e kit |
| EP2495320B1 (en) * | 2009-10-28 | 2019-02-27 | Japan Health Sciences Foundation | Method for induction of differentiation of stem cells into hepatocytes |
| JPWO2011096482A1 (ja) * | 2010-02-03 | 2013-06-13 | 国立大学法人 東京大学 | 多能性幹細胞を用いた免疫機能再建法 |
| US20120009158A1 (en) * | 2010-06-18 | 2012-01-12 | The General Hospital Corporation | VENTRICULAR INDUCED PLURIPOTENT STEM (ViPS) CELLS FOR GENERATION OF AUTOLOGOUS VENTRICULAR CARDIOMYOCYTES AND USES THEREOF |
| KR101572344B1 (ko) * | 2011-05-13 | 2015-11-26 | 고쿠리츠다이가쿠호우진 도쿄다이가쿠 | 다핵화 거핵구 세포, 및 혈소판의 제조방법 |
| US9677141B2 (en) * | 2011-07-25 | 2017-06-13 | Kyoto University | Method for screening induced pluripotent stem cells |
| JP2013240308A (ja) * | 2012-05-23 | 2013-12-05 | Kagoshima Univ | ヒトＥＳ／ｉＰＳ細胞における遺伝子発現方法 |
| EP2955223B1 (en) * | 2013-02-08 | 2019-12-18 | Kyoto University | Production methods for megakaryocytes and platelets |
| EP2977449B1 (en) | 2013-03-21 | 2020-02-26 | Kyoto University | Pluripotent stem cell for neuronal differentiation induction |
-
2016
- 2016-04-14 JP JP2017512584A patent/JP6873898B2/ja active Active
- 2016-04-14 US US15/565,922 patent/US20180051260A1/en not_active Abandoned
- 2016-04-14 BR BR112017022219A patent/BR112017022219A2/pt not_active Application Discontinuation
- 2016-04-14 SG SG11201708395VA patent/SG11201708395VA/en unknown
- 2016-04-14 RU RU2017139241A patent/RU2730034C2/ru active
- 2016-04-14 WO PCT/JP2016/062040 patent/WO2016167329A1/ja active Application Filing
- 2016-04-14 EP EP16780120.8A patent/EP3296390B1/en active Active
- 2016-04-14 CN CN201680034787.0A patent/CN107709543B/zh active Active
- 2016-04-14 KR KR1020177032755A patent/KR102563564B1/ko active IP Right Grant
- 2016-04-14 AU AU2016248858A patent/AU2016248858A1/en not_active Abandoned
- 2016-04-14 CA CA2982568A patent/CA2982568A1/en not_active Abandoned
-
2017
- 2017-10-15 IL IL255031A patent/IL255031B/en unknown
-
2020
- 2020-04-03 US US16/839,906 patent/US20210062158A1/en not_active Abandoned
-
2023
- 2023-09-27 US US18/476,065 patent/US20240026304A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6873898B2 (ja) | 2021-05-19 |
| RU2730034C2 (ru) | 2020-08-14 |
| KR20180019519A (ko) | 2018-02-26 |
| JPWO2016167329A1 (ja) | 2018-02-15 |
| IL255031A0 (en) | 2017-12-31 |
| RU2017139241A3 (ru) | 2019-09-16 |
| EP3296390A1 (en) | 2018-03-21 |
| AU2016248858A1 (en) | 2017-11-09 |
| SG11201708395VA (en) | 2017-11-29 |
| US20240026304A1 (en) | 2024-01-25 |
| CN107709543A (zh) | 2018-02-16 |
| WO2016167329A1 (ja) | 2016-10-20 |
| US20180051260A1 (en) | 2018-02-22 |
| KR102563564B1 (ko) | 2023-08-07 |
| BR112017022219A2 (pt) | 2018-07-31 |
| EP3296390B1 (en) | 2023-01-04 |
| IL255031B (en) | 2022-04-01 |
| CN107709543B (zh) | 2021-11-09 |
| CA2982568A1 (en) | 2016-10-20 |
| US20210062158A1 (en) | 2021-03-04 |
| EP3296390A4 (en) | 2019-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015019950A2 (pt) | Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro | |
| IL290744A (en) | Methods for the production of autologous t cells used in the treatment of b-cell malignancies and other types of cancer and preparations thereof | |
| IL290605A (en) | Methods for the production of hematopoietic progenitor cells from pluripotent stem cells | |
| EA201992615A1 (ru) | Способы выделения клеток без использования трансгенных маркерных последовательностей | |
| PH12017502283A1 (en) | A method of treatment | |
| WO2012109208A3 (en) | Hematopoietic precursor cell production by programming | |
| WO2015157647A3 (en) | Guiding stem cell differentiation using graphene-nanofiber hybrid scaffolds | |
| SG11202104417UA (en) | Cell culture process by intensified perfusion with continuous harvest and without cell bleeding | |
| IL282637A (en) | Methods for allogeneic transplantation of hematopoietic stem cells | |
| EP3927370B8 (en) | Methods for producing autologous t cells useful to treat cancers and compositions thereof | |
| MX2016012691A (es) | Nuevos compuestos de succinato permeables a la celula. | |
| MY184796A (en) | Method for manufacturing ciliary marginal zone-like structure | |
| AR097981A1 (es) | Interferencia de la represión del factor de transcripción hd-zip de expresión génica para la producción de plantas con rasgos mejorados | |
| EA202091325A1 (ru) | Способы лечения с помощью лигандов лантионин c-подобного белка 2 и подготовленных с их помощью клеток | |
| SG11201806177QA (en) | Transplant material for treatment of heart disease | |
| BR112017020513A2 (pt) | método de produção de peixe para transplante, peixe para transplante, método de produção de espécie híbrida de peixe e espécie híbrida de peixe | |
| WO2017213469A3 (ko) | 남조류 스피룰리나 추출물을 함유하는 세포 배양액, 이의 제조방법, 및 이를 이용한 세포의 배양방법 | |
| PH12016502024A1 (en) | Tonoplast proton/sugar antiporter proteins and the use thereof to increase the saccharose concentration in a saccharose storage organ of plants | |
| RU2017139241A (ru) | Способ получения клона стволовых клеток, пригодного для индуцирования дифференцировки в соматические клетки. | |
| Somorjai et al. | Stem cells: a view from the roots | |
| MX2021003383A (es) | Metodos para diferenciar celulas troncales mesenquimales. | |
| CO2021007824A2 (es) | Gen suicida | |
| EP4012022A4 (en) | METHOD FOR PRODUCING SKIN-DERIVED PLURIPOTENT PROGENITOR CELLS | |
| MY166810A (en) | Isolation, expansion and characterization of precursor/stem cells from dental tissues | |
| AR102044A1 (es) | Elementos reguladores de plantas y métodos para usarlos |